°µÍø³Ô¹Ï
Main navigation
°µÍø³Ô¹Ï
°µÍø³Ô¹Ï
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Read more
about CavaGroup-2023-06-14
$365.4 Million
Image
Cava Group, Inc.
Initial Public Offering
Active Bookrunner
Read more
about Akoya-2023-06-07
$50.0 Million
Image
Akoya Biosciences, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Lexicon-2023-05-31
$134.3 Million
Image
Lexicon Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering and PIPE Offering
Active Bookrunner
Read more
about Cogent-2023-06-07
$150.0 Million
Image
Cogent Biosciences
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about DayOneBio-2023-06-06
$172.5 Million
Image
Day One Biopharmaceuticals, Inc.
Confidentally Marketed Follow-On Offering
Active Bookrunner
Read more
about Corebridge-2023-06-08
$1.2 Billion
Image
Corebridge Financial, Inc
Follow-On Offering
Active Bookrunner
Read more
about Enfusion-2023-10-01
$318.8 Million
Image
Enfusion
Initial Public Offering
Active Bookrunner
Read more
about Corebridge-22-09-01
$1.7 Billion
Image
Image
Corebridge
Initial Public Offering
Active Bookrunner
Read more
about TELA-2023-04-18
$49.6 Million
Image
TELA Bio, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about ReneoPharmaceuticals-2023-05-03
$68.3 Million
Image
Reneo Pharmaceuticals
Confidentially Marketed Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹â¶Ä¹
Page 10
Next page
›â¶Äº
Subscribe to Active Bookrunner